Bullish Moving Averages
5
Bearish Moving Averages
11
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
237.50Today’s High
242.8052W low
88.6052W High
282.80Open Price
240.00Prev. Close
240.5000Volume
79762.00Value
18956236.92Fundamentals
Market Cap Cr
2178.70
Price to Earnings
17.60
Price to Book Value
4.60
Dividend Yield
1.30
PE to Growth
0.40
Op Revenue TTM Cr
1244.70
Net Profit TTM Cr
123.96
Cash From Operating Activity Cr
200.15
Return on Equity %
25.94
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
03 Jul, 2024
61.6
Week
65.1
Month
62.3
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
241.16
PIVOT
First Resistance
243.17
Second Resistance
246.31
Third Resistance
248.32
First Support
238.02
Second Support
236.01
Third Support
232.87
Relative Strength Index
46.04
Money Flow Index
35.35
MACD
-0.77
MACD Signal
0.65
Average True Range
10.76
Average Directional Index
10.32
Rate of Change (21)
0.14
Rate of Change (125)
34.47
Commodity Channel Index
-56.3
Williams %R
-82
BETA
1 Month
0.56
3 Month
0.77
1 Year
0.64
3 Year
0.48
PRICE CHANGE ANALYSIS
↓ -2.15%
1 Week
Low
High
234.79
248.94
↓ -0.85%
1 Month
Low
High
211.3
263.91
↑ 20.12%
3 Months
Low
High
199.55
282.8
↑ 29.48%
6 Months
Low
High
154.5
282.8
↑ 162.03%
1 Year
Low
High
88.65
282.8
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 319.62 | 310.73 | 321.17 | 310.07 | 278.84 | 280.01 | 285.76 | 264.09 | 217.55 | 237.22 | 233.36 | |
| Operating Expenses Qtr | 266.29 | 259.16 | 266.64 | 259.25 | 240.91 | 239.87 | 240.77 | 226.42 | 188.22 | 205.31 | 207.53 | |
| Operating Profit Qtr | 48.44 | 47.30 | 50.36 | 47.26 | 33.14 | 37.84 | 43.60 | 36.90 | 27.52 | 31.30 | 25.36 | |
| EBIDT Qtr Cr | 53.33 | 51.57 | 54.53 | 50.82 | 37.93 | 40.14 | 44.99 | 37.67 | 29.33 | 31.90 | 25.83 | |
| Depreciation Qtr | 10.21 | 10.03 | 10.03 | 9.81 | 9.86 | 9.86 | 9.85 | 9.70 | 8.64 | 8.80 | 8.72 | |
| Net Profit Qtr | 31.17 | 29.44 | 32.85 | 30.50 | 19.84 | 20.90 | 25.13 | 20.28 | 15.20 | 15.92 | 12.07 | |
| Basic EPS Qtr | 3.40 | 3.21 | 3.58 | 3.33 | 2.16 | 2.28 | 2.74 | 2.21 | 1.66 | 1.74 | 1.32 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1261.59 | 1108.70 | 891.28 | 614.06 | 831.46 | |
| Operating Expenses Annual Cr | 1051.34 | 947.97 | 773.86 | 573.11 | 744.38 | |
| Operating Profit Annual | 193.36 | 150.70 | 114.30 | 40.27 | 86.39 | |
| Operating Profit Margin Annual % | 15.33 | 13.59 | 12.82 | 6.56 | 10.39 | |
| Total Expenses Annual Cr | 1095.48 | 991.52 | 812.21 | 609.77 | 783.26 | |
| EBIDT Annual Cr | 210.25 | 160.73 | 117.42 | 40.95 | 87.08 | |
| EBIDT Annual margin % | 16.67 | 14.50 | 13.17 | 6.67 | 10.47 | |
| Depreciation | 40.08 | 39.27 | 34.94 | 33.32 | 32.97 | |
| PAT Before ExtraOrdinary Items Annual Cr | 123.96 | 86.15 | 58.62 | 2.33 | 43.62 | |
| Net Profit Annual | 123.96 | 86.15 | 58.62 | 2.33 | 43.62 | |
| Basic EPS Annual | 13.52 | 9.40 | 6.39 | 0.25 | 4.76 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 477.76 | 379.45 | 325.44 | 272.76 | 267.80 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 80.06 | 46.06 | 42.77 | 43.29 | 41.59 | |
| Total Current Liabilities Annual Cr | 165.42 | 129.63 | 93.50 | 115.91 | 139.60 | |
| Total Capital Plus Liabilities Annual Cr | 723.24 | 555.14 | 461.71 | 431.96 | 448.99 | |
| Fixed Assets Annual | 347.41 | 277.58 | 276.86 | 286.67 | 302.68 | |
| Total Non Current Assets Annual | 415.26 | 332.06 | 304.28 | 290.53 | 307.52 | |
| Total Current Assets Annual | 307.98 | 223.08 | 157.43 | 141.43 | 141.47 | |
| Total Assets Annual | 723.24 | 555.14 | 461.71 | 431.96 | 448.99 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 88.50 | 74.43 | 56.95 | 61.66 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 200.15 | 144.47 | 71.29 | 27.90 | 86.45 | |
| Cash from Investing Activity Annual | -158.43 | -107.91 | -51.10 | -20.16 | -40.19 | |
| Cash from Financing Annual Activity | -32.38 | -26.04 | -3.37 | -3.15 | -42.74 | |
| Net Cash Flow Annual | - | 10.52 | 16.82 | 4.59 | 3.51 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 52.12 | 41.39 | 35.50 | 29.75 | 29.21 | |
| ROE Annual % | 25.94 | 22.70 | 18.01 | 0.85 | 16.28 | |
| ROCE Annual % | 30.50 | 28.54 | 22.40 | 2.41 | 17.48 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| EBDIT Annual Margin % | 16.89 | 14.62 | 13.22 | 6.67 | 10.48 |
| Indicator | Graph |
|---|---|
| Total Qtr Revenue cr | |
| Operating Expenses Qtr | |
| Operating Profit Qtr | |
| EBIDT Qtr Cr | |
| Depreciation Qtr | |
| Net Profit Qtr | |
| Basic EPS Qtr |
| Indicator | Graph |
|---|---|
| Total Revenue Annual | |
| Operating Expenses Annual Cr | |
| Operating Profit Annual | |
| Operating Profit Margin Annual % | |
| Total Expenses Annual Cr | |
| EBIDT Annual Cr | |
| EBIDT Annual margin % | |
| Depreciation | |
| PAT Before ExtraOrdinary Items Annual Cr | |
| Net Profit Annual | |
| Basic EPS Annual |
| Indicator | Graph |
|---|---|
| Total ShareHolders Funds Annual | |
| Minority Interest Liability Annual Cr | |
| Total Non Current Liabilities Annual Cr | |
| Total Current Liabilities Annual Cr | |
| Total Capital Plus Liabilities Annual Cr | |
| Fixed Assets Annual | |
| Total Non Current Assets Annual | |
| Total Current Assets Annual | |
| Total Assets Annual | |
| Contingent Liabilities plus Commitments Annual Cr |
| Indicator | Graph |
|---|---|
| Cash from Operating Activity Annual | |
| Cash from Investing Activity Annual | |
| Cash from Financing Annual Activity | |
| Net Cash Flow Annual |
| Indicator | Graph |
|---|---|
| Book Value Per Share Annual | |
| ROE Annual % | |
| ROCE Annual % | |
| Total Debt to Total Equity Annual | |
| EBDIT Annual Margin % |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| President of India | 26 | 74218526 | 0 | 0 |
| Hdfc Bank Limited | 4.91 | 74218532 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| President of India | 26 | 74218526 | 0 | 0 |
| Apollo Hospitals Enterprise Limited | 22.02 | 74218523 | 0 | 0 |
| Wedgewood Holdings Limited | 1.61 | 74218528 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Hdfc Bank Limited | 4.91 | 74218532 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| HUF | 1.58 | 74218537 |
| LLP | 0.68 | 74218538 |
| Emedlife Insurance Broking Services Limited | 1.72 | 74218542 |
| Citadel Research And Solutions Limited | 1.31 | 74218543 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Sep 15, 2023 | 3 | FINAL | - | Equity Share |
| Sep 15, 2022 | 2.5 | FINAL | - | Equity Share |
| Sep 12, 2019 | 1.6 | FINAL | - | Equity Share |
| Sep 12, 2018 | 1.5 | FINAL | - | Equity Share |
| Sep 14, 2017 | 1.8 | FINAL | - | Equity Share |
| Aug 18, 2016 | 1.8 | FINAL | - | Equity Share |
| Sep 16, 2015 | 1.8 | FINAL | - | Equity Share |
| Sep 18, 2014 | 1.8 | FINAL | - | Equity Share |
| Sep 19, 2013 | 1.6 | FINAL | - | Equity Share |
| Sep 06, 2012 | 1.6 | FINAL | - | Equity Share |
| Sep 05, 2011 | 1.6 | FINAL | - | Equity Share |
| Aug 30, 2010 | 1.6 | FINAL | - | Equity Share |
| Aug 27, 2009 | 1.5 | FINAL | - | Equity Share |
| Aug 28, 2008 | 1.4 | FINAL | - | Equity Share |
| Sep 07, 2007 | 1.25 | FINAL | - | Equity Share |
| Jul 28, 2006 | 1.25 | FINAL | - | Equity Share |
| Aug 18, 2005 | 1 | FINAL | - | Equity Share |
| Aug 18, 2004 | 1 | FINAL | - | Equity Share |
| Aug 13, 2003 | 0.85 | FINAL | - | Equity Share |
| Sep 06, 2002 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 17, 2024 | Audited Results & Final Dividend | - |
| Feb 06, 2024 | Quarterly Results | - |
| Nov 03, 2023 | Quarterly Results | - |
| Aug 04, 2023 | Quarterly Results | - |
| May 23, 2023 | Audited Results & Dividend | - |
| Feb 08, 2023 | Quarterly Results | - |
| Nov 04, 2022 | Quarterly Results | - |
| Aug 08, 2022 | Quarterly Results | - |
| Feb 08, 2022 | Quarterly Results | - |
| Nov 09, 2021 | Quarterly Results | - |
| Aug 09, 2021 | Quarterly Results | - |
| Jun 09, 2021 | Audited Results | - |
| Feb 08, 2021 | Quarterly Results | - |
| Nov 10, 2020 | Quarterly Results | - |
| Aug 24, 2020 | Quarterly Results | - |
| May 23, 2020 | Audited Results | - |
| Feb 03, 2020 | Quarterly Results | - |
| Nov 05, 2019 | Quarterly Results | - |
| Jul 26, 2019 | Quarterly Results | - |
| May 08, 2019 | Audited Results & Dividend | - |
| Jan 30, 2019 | Quarterly Results | - |
| Nov 10, 2018 | Quarterly Results | - |
| Jul 28, 2018 | Quarterly Results | - |
| May 09, 2018 | Audited Results & Dividend | - |
| Feb 07, 2018 | Quarterly Results | - |
| Nov 14, 2017 | Quarterly Results | - |
| Jul 28, 2017 | Quarterly Results | - |
| May 26, 2017 | Audited Results & Dividend | - |
| Jan 30, 2017 | Quarterly Results | - |
| Nov 22, 2016 | Quarterly Results | Revised from 15/11/2016 |
| Aug 30, 2016 | Quarterly Results | - |
| May 20, 2016 | Audited Results & Dividend | - |
| Mar 31, 2016 | Others | 1. Re-appointed Dr. B. Venkataraman as Independent Director of the Company. 2. Re-appointed Prof. V. N. Rajasekharan Pillai as Independent Director of the Company. |
| Feb 02, 2016 | Quarterly Results | (Revised from 09/02/2016) |
| Nov 03, 2015 | Quarterly Results | - |
| Aug 07, 2015 | Quarterly Results | - |
| May 26, 2015 | Audited Results & Dividend | Appointed Mr. Arun Rai as an Independent Director of the Company.(Revised from 25/05/2015) |
| Jan 29, 2015 | Quarterly Results | - |
| Nov 07, 2014 | Quarterly Results | - |
| Jul 25, 2014 | Quarterly Results | - |
| May 23, 2014 | Audited Results & Dividend | - |
| Jan 28, 2014 | Quarterly Results | - |
| Nov 06, 2013 | Quarterly Results | - |
| Jul 26, 2013 | Quarterly Results | - |
| May 07, 2013 | Audited Results & Dividend | - |
| Feb 13, 2013 | Quarterly Results | - |
| Nov 02, 2012 | Quarterly Results | - |
| Aug 01, 2012 | Quarterly Results | - |
| May 23, 2012 | Audited Results & Dividend | - |
| Feb 14, 2012 | Quarterly Results | - |
| Nov 12, 2011 | Quarterly Results | - |
| Jul 30, 2011 | Quarterly Results | - |
| May 12, 2011 | Audited Results & Dividend | - |
| Feb 09, 2011 | Quarterly Results | - |
| Nov 02, 2010 | Quarterly Results | - |
| Jul 28, 2010 | Quarterly Results | - |
| Apr 27, 2010 | Audited Results & Dividend | - |
| Jan 23, 2010 | Quarterly Results | - |
| Oct 21, 2009 | Quarterly Results | - |
| Jul 28, 2009 | Quarterly Results | - |
| Apr 30, 2009 | Audited Results & Dividend | - |
| Jan 23, 2009 | Quarterly Results | - |
| Oct 22, 2008 | Quarterly Results | - |
| Jul 25, 2008 | Quarterly Results | - |
| Jun 09, 2008 | Audited Results & Dividend | - |
| Jan 29, 2008 | Quarterly Results | - |
| Oct 12, 2007 | Quarterly Results | - |
| Jul 26, 2007 | Quarterly Results | - |
| May 29, 2007 | Audited Results & Dividend | - |
| Jan 29, 2007 | Quarterly Results | - |
| Nov 27, 2006 | Half Yearly Results | - |
| Jul 28, 2006 | Quarterly Results | - |
| May 20, 2006 | Accounts & Dividend | - |
| Jan 25, 2006 | Quarterly Results | - |
| Nov 19, 2005 | Half Yearly Results | - |
| Jul 27, 2005 | Quarterly Results | - |
| May 20, 2005 | Accounts & Dividend | - |
| Jan 24, 2005 | Quarterly Results | - |
| Nov 19, 2004 | Half Yearly Results | - |
| Jul 26, 2004 | Quarterly Results | - |
| May 20, 2004 | Dividend | - |
| Jan 21, 2004 | Quarterly Results | - |
| Nov 21, 2003 | Accounts | - |
| Jul 25, 2003 | Quarterly Results | - |
| Jun 27, 2003 | Accounts | - |
| Jan 10, 2003 | Quarterly Results | - |
| Oct 29, 2002 | Quarterly Results | - |
| Jul 26, 2002 | Quarterly Results | - |
| Jun 28, 2002 | Accounts | - |
| Jan 10, 2002 | Quarterly Results | - |
| Oct 17, 2001 | Half Yearly Results | - |
| Jul 27, 2001 | Quarterly Results | - |
| May 31, 2001 | Accounts | - |
| Jan 31, 2001 | Quarterly Results | - |
| Sep 14, 2000 | Interim Dividend | - |
| Jul 27, 2000 | Quarterly Results | - |
| Jun 22, 2000 | Accounts | - |
| Jan 25, 2000 | Quarterly Results | - |
| Oct 29, 1999 | Quarterly Results | - |
| Jul 27, 1999 | Quarterly Results | - |
| Apr 17, 1999 | Quarterly Results | - |
| Oct 30, 1998 | Half Yearly Results | - |
| Jun 30, 1998 | Accounts | - |
| Dec 30, 1997 | Half Yearly Results | - |
| Dec 19, 1997 | Half Yearly Results | - |
| Aug 20, 1997 | Accounts | - |
| Jun 28, 1997 | Accounts | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
01 Jul 2024
INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform you that the company has received following details from shareholder : 1. Hitesh Khanna Jt. Anuj Khanna Folio No 17471, No. of shares 200, Certificate No -132121- 132122, Distinctive No- 81998701-81998900 2. Tarun Narula folio No6854, No of shares-200, Certificate Nos-44110-44111, Distinctive Nos 71830801- 71831000
29 Jun 2024
INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform you that the Company has received intimation from following shareholders: 1. Daniel Massy Folio No-9151, No. of shares -200, Certificate No- 82000 to 82001, Distinctive No- 76353501 to 76353700 2. Bharat Bhushan, folio No-3638, No. of share -200, Certificate No-32182 to 32183, Distinctive No-70638001 to 70638200 3. Vivek Kapoor, Folio No-11521, No of shares-500, Certificate Nos-91826 to 91830, Distinctive no''s- 77336101- 77336600
26 Jun 2024
INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window
It is to hereby informed that Trading Window for Trading window for dealing in shares of the company, will remain closed from effect of 1st Jusly,2024 till 48 hours after declaration of un-audited financial results for the quarter ending, 30th June, 2024.
24 Jun 2024
INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform you that company has received information for loss of share certificate as follows: 1. Smita S Joshi- Folio No. 20490, No. Of Shares-100, Certificate No-13747, Distinctive No- 68794501-68794600 2. Pushpa Devi- Folio No. 23030, No of shares-500, Certificate Nos- 159470 to 159471, 60539, 92223 to 92224, Distinctive Nos- 84733601 to 84733800, 74207401 to 74207500, 77375801 to 77376000
05 Jun 2024
INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We hereby submit copy of the public notice of loss of share certificates, published on 5th June,2024, in the Financial Express Delhi edition.
04 Jun 2024
INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
this is to inform you that the company has received intimation from the following shareholder: 1 Vinit Suri Jt. Neelam Suri Folio No- 642, No Of Shares-5000, Certificate No- 196162, Distinctive No- 54269702-54274701. 2. Vinit Suri Jt. Neelam Suri Folio No- 8338, No of Shares 3700, Certificate Nos. 196163, Distinctive Nos. 75840801-75844500.
20 May 2024
INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg.24(A)-Annual Secretarial Compliance
We hereby submit Annual secretarial compliance report from a practicing Company Secretary, for the year ended 31st March, 2024.
18 May 2024
INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We hereby submits the copies of the public notice of the financial results, published on 18th May, 2024, in the Financial Express, all India edition, in English language and in Jansatta, Delhi edition in Hindi language.
17 May 2024
INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Outcome for Approval Of Audited Financial Results & Recommendation Of Dividend For The Financial Year 2023-24
The Board of Directors of the Company at its meeting held on 17th May, 2024 i.e. today, interalia: 1. Approved audited financial statements for the year ended 31st March, 2024; and 2. Recommended a dividend @45% i.e. Rs. 4.50 per share for the financial year 2023-24. Details are given in the enclosed letter.
17 May 2024
INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Audited Financial Results For The Quarter And Year Ended 31St March, 2024
this is to inform that the Board of directors of the company has, at its meeting held on Friday,17th May,2024 inter-alia: 1. approved the audited Financial Statements for the year ended 31st Marc,2024. 2 Recommended a dividend @45% i.e, Rs 4.5 per share for te financial year 2023-24 Details are given in the annexures.
